Home/Filings/4/0001562180-22-007667
4//SEC Filing

Greene Barry E 4

Accession 0001562180-22-007667

CIK 0001597553other

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 4:04 PM ET

Size

6.9 KB

Accession

0001562180-22-007667

Insider Transaction Report

Form 4
Period: 2022-11-10
Greene Barry E
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2022-11-10$34.48/sh+14,500$500,02246,940 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $34.19 USD to $34.86 USD. The price reported above reflects the weighted average purchase price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001291963

Filing Metadata

Form type
4
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:04 PM ET
Size
6.9 KB